Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$1.39
EPS est.
$1.21
EPS surprise
+14.78%
1-day move
+6.86%
Teleflex's earnings report showed a strong performance in EPS, exceeding expectations by nearly 15%. This positive surprise likely contributed to the stock's 6.86% increase in value. However, the lack of revenue data and management commentary leaves some uncertainty about the company's overall performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.39 | $1.22 | +14.78% |
| Revenue | N/A | $538M | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Teleflex Incorporated (TFX) is a global provider of medical technologies, focusing on innovative solutions in the healthcare equipment sector. With a market cap of $5 billion, the company plays a vital role in improving patient outcomes and enhancing the efficiency of healthcare delivery.
Last quarter
In Q4-2025, Teleflex reported an EPS of $1.93, which was significantly below the expected $3.73, leading to a 6.37% increase in stock price the following day. This marked a notable surprise and raised concerns about the company's ability to meet future expectations.
Management promises and guidance
EPS beat streak
2Q
EPS beat rate
88%
Avg EPS surprise
+3.57%
Avg 1-day reaction
-4.71%
Analysts are cautiously optimistic about Teleflex's upcoming earnings, with expectations for an EPS of $1.22 and revenue of $538 million. The company has a history of beating EPS estimates, which could influence market reactions.
Bull case
If Teleflex can exceed the EPS estimate and show strong revenue growth, it may signal a recovery in operational performance and boost investor confidence.
Bear case
Conversely, if the company misses expectations again, it could raise further doubts about its growth strategy and lead to a significant decline in stock price.
Key metrics to watch
EPS
$1.22Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$538MTotal revenue reflects the overall sales performance and market demand for Teleflex's products.
The print will turn on these.
Q1
Will Teleflex's EPS meet or exceed the consensus estimate of $1.22?
This figure is crucial for assessing the company's profitability and could significantly impact stock performance.
Q2
What is the outlook for revenue growth relative to the consensus of $538 million?
Revenue performance will indicate market demand for Teleflex's products and the effectiveness of its growth strategies.
—
Est. EPS
$0.14
Est. Rev
$2.4B
Impl. Move
±9.5%
Why consensus could be wrong
The Street may be underestimating Teleflex's ability to recover from its last earnings miss, as the company has a strong track record of innovation and operational improvements.
Supporting evidence
Teleflex has consistently beaten EPS estimates in the past, suggesting potential for a positive surprise.
The options market is pricing a lower move than historical averages, indicating a potential mispricing of volatility.
Management's focus on R&D investments could lead to stronger product offerings and market demand.
Key risk
If the company demonstrates significant revenue growth, it could challenge the bearish sentiment currently surrounding its stock.
Pre-commit to what would confirm each case.
This quarter's performance is critical for Teleflex as it seeks to regain investor confidence after a disappointing previous quarter.
Bull confirmed if
An EPS of $1.25 or higher, coupled with revenue exceeding $550 million, would confirm strong operational recovery.
Bear confirmed if
An EPS below $1.15 or revenue falling short of $520 million would raise serious concerns about the company's growth trajectory.
What the market is pricing for the move.
Implied Move
±6.72%
Historical Avg
±9.6%
The options market is pricing in a move of approximately 6.72%, suggesting that traders expect some volatility around the earnings announcement.
Options are pricing ±8.0% while TFX has averaged ±9.6% over the last 8 prints — setup is pricing cheap.
ATM IV
0.7%
30d HV
51.7%
Cross-company pattern from 30 similar setups.
Prior-quarter miss + options pricing cheap setup in Health Care
Fade rate: 4 of 11 (36%)
This setup has occurred 30 times across Health Care in the last 2 years. 7 of 11 (64%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 5.5%, with a raw directional average of +3.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
114.85%
of float
Insider
0.63%
of float
Holders
504
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
5,431,818 sh · $676.2M
12.82%
0.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Teleflex beats expectations, history suggests a potential average move of +7.39%, confirming a positive outlook for the company.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further clarity on future guidance.
Miss
Should the company miss estimates, history indicates an average decline of +6.37%, which could lead to increased skepticism about its growth strategy.
The lines on the call that would change the story.
Jupiter Topco LLC
4,342,512 sh · $540.6M
10.25%
100.0%
T. Rowe Price Investment Management, Inc.
3,194,710 sh · $397.7M
7.54%
-16.7%
Vanguard Portfolio Management LLC
2,416,998 sh · $300.9M
5.70%
-0.9%
Vanguard Capital Management LLC
1,995,717 sh · $248.4M
4.71%
0.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.